alloxan has been researched along with curcumin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Cheng, B; Li, M; Miao, M | 1 |
| Costi, R; Crucitti, GC; Das, KK; Dhundasi, SA; Di Santo, R; Jargar, JG; Messore, A; Pescatori, L; Razzaghi-Asl, N; Saso, L; Tikare, SN | 1 |
| Chen, WB; Jiang, X; Li, K; Li, LX; Liu, YQ; Wang, YX; Xia, ZH | 1 |
| Ageeva, TA; Aĭzman, RI; Koroshchenko, GA; Sazonova, OV; Selivanova, SV; Subotialov, MA; Trofimovich, EM | 1 |
| Ahmad, M; Kamran, SH; Mobasher, A | 1 |
| Omar, AG; Raafat, KM | 1 |
| Najam, R; Rao, SS | 1 |
8 other study(ies) available for alloxan and curcumin
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Effect of curcumin on diabetic rat model of cerebral ischemia.
Topics: Alloxan; Animals; Blood Glucose; Brain; Brain Ischemia; Curcumin; Diabetes Mellitus, Experimental; Energy Metabolism; Male; Neuroglia; Rats; Rats, Sprague-Dawley | 2015 |
Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats.
Topics: Administration, Oral; Alloxan; Animals; Blood Glucose; Curcumin; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Male; Molecular Structure; Rats; Rats, Wistar; Structure-Activity Relationship | 2016 |
Curcumin inhibits alloxan-induced pancreatic islet cell damage via antioxidation and antiapoptosis.
Topics: Alloxan; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line; Curcumin; Insulin-Secreting Cells; Malondialdehyde; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase | 2020 |
[To question about integrated prevention of diabetes taking into account the technogenic factors of environment (experimental results)].
Topics: Alloxan; Animals; Antioxidants; Curcuma; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Environmental Pollutants; Formaldehyde; Hypoglycemic Agents; Insulin-Secreting Cells; Kidney; Liver; Male; Oxidative Stress; Plant Preparations; Rats; Rats, Wistar | 2012 |
Protective effect of crude Curcuma longa and its methanolic extract in alloxanized rabbits.
Topics: Alanine Transaminase; Alloxan; Animals; Antioxidants; Blood Glucose; Curcuma; Diabetes Mellitus, Experimental; Liver; Male; Phytotherapy; Plant Extracts; Rabbits | 2014 |
Phytotherapeutic activity of curcumol: Isolation, GC-MS identification, and assessing potentials against acute and subchronic hyperglycemia, tactile allodynia, and hyperalgesia.
Topics: Alloxan; Analgesics; Animals; Antioxidants; Biomarkers; Blood Glucose; Curcuma; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Hyperalgesia; Hypoglycemic Agents; Male; Mice; Pain Threshold; Phytotherapy; Plants, Medicinal; Reaction Time; Rhizome; Sesquiterpenes; Time Factors | 2016 |
Efficacy of combination herbal product (Curcuma longa and Eugenia jambolana) used for diabetes mellitus.
Topics: Alloxan; Animals; Blood Glucose; Curcuma; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Glycated Hemoglobin; Male; Plant Extracts; Rats; Rats, Wistar; Syzygium | 2016 |